We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
FEMSelect’s EnPlace meshless pelvic floor ligament fixation system had positive results in a four-year prospective follow-up study of 14 patients, the company said in a Tuesday statement. Read More
The development of the product was funded by HHS’ Administration for Strategic Preparedness and Response as well as the Biomedical Advanced Research and Development Authority. Read More
The Regeneten Biodinductive Implant from Britain’s Smith+Nephew delivered an 86 percent reduction in rotator cuff re-tear rates at 12 months, according to interim study results presented at a conference last week in Dublin. Read More
New research published in the NEJM Evidence shows potential for Nordic Bioscience’s PRO-C6 assay becoming a next-generation biomarker in trials studying patients with heart failure with preserved ejection fraction (HFpEF). Read More
An experimental radiotracer known as [18F]flurpiridaz has met its two primary endpoints of exceeding a 60 percent threshold for both sensitivity and specificity in detecting coronary artery disease (CAD), according to the sponsors, GE Healthcare and Lantheus. Read More